Pohang, South Korea · Founded 2011 · Privately Held (backing)
Operator of a biotechnology company intended to offer a plant-derived genetically modified subunit vaccine for the prevention of swine fever. Bio App is based in Pohang, South Korea and was founded in 2011. Its last reported valuation was $87.3 million in Jul 2022. It has raised $3.8 million.
Last reported valuation
$87.3M
Oct 2026
Priced at
—
Total raised
$3.8M
Last round
—
Cap table — not yet on record
Bio App's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bio App with a free account
·Watch Bio App: the Monday email on marks, rounds and moves
